• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晚期癌症患者居家随访中的姑息性镇静:一项前瞻性研究。

Palliative sedation in patients with advanced cancer followed at home: a prospective study.

作者信息

Mercadante Sebastiano, Porzio Giampiero, Valle Alessandro, Aielli Federica, Casuccio Alessandra

机构信息

Pain Relief and Palliative Care Unit, La Maddalena Cancer Center, Palermo, Italy; Palliative Medicine, Department of Anesthesia & Intensive Care, University of Palermo, Palermo, Italy.

Home Care Program, L' Aquila per la vita, L'Aquila, Italy.

出版信息

J Pain Symptom Manage. 2014 May;47(5):860-6. doi: 10.1016/j.jpainsymman.2013.06.019. Epub 2013 Oct 5.

DOI:10.1016/j.jpainsymman.2013.06.019
PMID:24099896
Abstract

CONTEXT

Home care programs in Italy.

OBJECTIVES

The aim of this study was to assess a protocol for palliative sedation (PS) performed at home.

METHODS

A total of 219 patients were prospectively assessed to evaluate a PS protocol in patients with advanced cancer followed at home by two home care programs with different territorial facilities. The protocol was based on stepwise administration of midazolam.

RESULTS

A total of 176 of the patients died at home, and PS was performed in 24 of these patients (13.6%). Younger patients received the procedure more frequently than older patients (P=0.012). The principal reasons to start PS were agitated delirium (n=20) and dyspnea (n=4). Mean duration of PS was 42.2±30.4 hours, and the mean doses of midazolam were 23-58 mg/day. Both the home care team and the patients' relatives expressed optimal or good levels of satisfaction with the procedure in all but one case, respectively.

CONCLUSION

This protocol for PS was feasible and effective in minimizing distress for a subgroup of patients who died at home. The characteristics of patients who may be effectively sedated at home should be better explored in future studies.

摘要

背景

意大利的居家护理项目。

目的

本研究旨在评估一项在家中实施的姑息性镇静(PS)方案。

方法

前瞻性评估了总共219例患者,以评价在两个具有不同地域设施的居家护理项目下,对晚期癌症患者实施的PS方案。该方案基于咪达唑仑的逐步给药。

结果

总共176例患者在家中死亡,其中24例(13.6%)接受了PS。年轻患者接受该操作的频率高于老年患者(P = 0.012)。启动PS的主要原因是激越性谵妄(n = 20)和呼吸困难(n = 4)。PS的平均持续时间为42.2±30.4小时,咪达唑仑的平均剂量为23 - 58毫克/天。除1例患者外,居家护理团队和患者亲属分别对该操作表示了最佳或良好的满意度。

结论

该PS方案在使在家中死亡的一部分患者的痛苦最小化方面是可行且有效的。未来研究应更好地探索可能在家中有效镇静的患者特征。

相似文献

1
Palliative sedation in patients with advanced cancer followed at home: a prospective study.晚期癌症患者居家随访中的姑息性镇静:一项前瞻性研究。
J Pain Symptom Manage. 2014 May;47(5):860-6. doi: 10.1016/j.jpainsymman.2013.06.019. Epub 2013 Oct 5.
2
Palliative sedation in advanced cancer patients followed at home: a retrospective analysis.晚期癌症患者居家姑息镇静治疗的回顾性分析。
J Pain Symptom Manage. 2012 Jun;43(6):1126-30. doi: 10.1016/j.jpainsymman.2011.06.027.
3
Continuous palliative sedation for patients with advanced cancer at a tertiary care cancer center.在一家三级癌症治疗中心对晚期癌症患者进行持续姑息性镇静治疗。
BMC Palliat Care. 2018 Jan 4;17(1):13. doi: 10.1186/s12904-017-0264-2.
4
Palliative sedation at home for terminally ill children with cancer.为身患癌症的晚期儿童在家中实施姑息性镇静。
J Pain Symptom Manage. 2014 Nov;48(5):968-74. doi: 10.1016/j.jpainsymman.2014.01.012. Epub 2014 Apr 18.
5
Efficacy and safety of deep, continuous palliative sedation at home: a retrospective, single-institution study.家庭中深度、持续姑息性镇静的疗效和安全性:一项回顾性、单机构研究。
Support Care Cancer. 2010 Jan;18(1):77-81. doi: 10.1007/s00520-009-0632-4. Epub 2009 Apr 3.
6
Sedation at the end of life - a nation-wide study in palliative care units in Austria.临终镇静——奥地利姑息治疗病房的一项全国性研究。
BMC Palliat Care. 2016 May 14;15:50. doi: 10.1186/s12904-016-0121-8.
7
Palliative sedation in patients with advanced cancer followed at home: a systematic review.晚期癌症患者居家姑息镇静治疗的系统评价。
J Pain Symptom Manage. 2011 Apr;41(4):754-60. doi: 10.1016/j.jpainsymman.2010.07.013. Epub 2011 Jan 12.
8
Belgian general practitioners' perspectives on the use of palliative sedation in end-of-life home care: a qualitative study.比利时全科医生对临终家庭护理中使用姑息性镇静的看法:一项定性研究。
J Pain Symptom Manage. 2014 Jun;47(6):1054-63. doi: 10.1016/j.jpainsymman.2013.06.016. Epub 2013 Oct 2.
9
[Palliative care for patients with COPD: a challenge].[慢性阻塞性肺疾病患者的姑息治疗:一项挑战]
Rev Mal Respir. 2012 Nov;29(9):1088-94. doi: 10.1016/j.rmr.2012.04.010. Epub 2012 Jul 24.
10
Palliative Sedation in Terminal Cancer Patients Admitted to Hospice or Home Care Programs: Does the Setting Matter? Results From a National Multicenter Observational Study.终末期癌症患者在临终关怀或家庭护理项目中接受姑息性镇静:环境是否重要?一项全国多中心观察性研究的结果。
J Pain Symptom Manage. 2018 Jul;56(1):33-43. doi: 10.1016/j.jpainsymman.2018.03.008. Epub 2018 Mar 13.

引用本文的文献

1
Palliative sedation rate for noncancer terminally ill patients at home in Japan.日本居家非癌症末期患者的姑息性镇静率。
BMC Palliat Care. 2025 Jun 4;24(1):158. doi: 10.1186/s12904-025-01799-y.
2
Dexmedetomidine Versus Midazolam for End-of-Life Sedation and Agitation: Protocol for a Randomized Controlled Trial (The DREAMS Trial).右美托咪定对比咪达唑仑用于终末镇静和激越:一项随机对照试验方案(DREAMS 试验)。
JMIR Res Protoc. 2024 Sep 4;13:e55129. doi: 10.2196/55129.
3
Prevalence of Delirium in Advance Cancer Patients Admitted in Hospice Centre and Outcome after Palliative Intervention.
临终关怀中心收治的晚期癌症患者谵妄的患病率及姑息治疗干预后的结局
Indian J Palliat Care. 2023 Jan-Mar;29(1):82-88. doi: 10.25259/IJPC_114_2022. Epub 2022 Sep 7.
4
"It's pretty much flying blind in the home care setting": A qualitative study on the influence of home care specific circumstances on sedation in specialist palliative home care.“在家庭护理环境中几乎是盲目行事”:一项关于家庭护理特殊情况对专科姑息家庭护理中镇静作用影响的定性研究
Palliat Med. 2023 Jan;37(1):140-148. doi: 10.1177/02692163221128938. Epub 2022 Oct 14.
5
Sedation in specialized palliative care: A cross-sectional study.专科姑息治疗中的镇静:一项横断面研究。
PLoS One. 2022 Jul 8;17(7):e0270483. doi: 10.1371/journal.pone.0270483. eCollection 2022.
6
Association of the RASS Score with Intensity of Symptoms, Discomfort, and Communication Capacity in Terminally Ill Cancer Patients Receiving Palliative Sedation: Is RASS an Appropriate Outcome Measure?接受姑息性镇静的晚期癌症患者中RASS评分与症状强度、不适及沟通能力的关联:RASS是一个合适的结局指标吗?
Palliat Med Rep. 2022 Apr 8;3(1):47-54. doi: 10.1089/pmr.2021.0087. eCollection 2022.
7
The Decision-Making Process for Palliative Sedation for Patients with Advanced Cancer-Analysis from a Systematic Review of Prospective Studies.晚期癌症患者姑息性镇静的决策过程——基于前瞻性研究系统评价的分析
Cancers (Basel). 2022 Jan 8;14(2):301. doi: 10.3390/cancers14020301.
8
Factors Influencing Pain Expression in Patients with Cancer: An Expert Opinion.影响癌症患者疼痛表达的因素:专家意见
Pain Ther. 2021 Dec;10(2):765-775. doi: 10.1007/s40122-021-00272-x. Epub 2021 May 20.
9
How to measure the effects and potential adverse events of palliative sedation? An integrative review.如何衡量姑息性镇静的效果和潜在不良事件?一项综合综述。
Palliat Med. 2021 Feb;35(2):295-314. doi: 10.1177/0269216320974264. Epub 2020 Dec 14.
10
Midazolam: an essential palliative care drug.咪达唑仑:一种重要的姑息治疗药物。
Palliat Care Soc Pract. 2020 Jan 13;14:2632352419895527. doi: 10.1177/2632352419895527. eCollection 2020.